Smart Therapeutic Nanoplatform Based on Ti 3 C 2 MXenes for Tumor-Targeted PTT/PDT/CHT at Low Temperatures
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.5c00659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Zhiqiang Bai und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong 037009, P. R.…. Hauptthemen laut MEDLINE: Photochemotherapy, Titanium, Nanoparticles, Photothermal Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Program of Shanxi Datong University, Key Scientific and Technological Projects of Datong City.
Abstract (Originalsprache)
Thermal injury to surrounding normal organs resulting from hyperthermia (>50 °C) is the main challenge in photothermal therapy (PTT) of tumors. Thus, significant effort should be directed toward developing photothermal strategies that deliver robust cancer cell killing under mild hyperthermia (≤45 °C). Herein, a multimodal therapeutic nanoplatform Ti3C2/ICG/PDA/GA/Apt-M (TIPGA) was developed for active targeted tumor therapy at low temperatures. In the TIPGA therapeutic nanoplatform, Ti3C2 MXenes were employed as photothermal agents (PTAs) to produce therapeutic heat upon near-infrared light irradiation, and indocyanine green (ICG) endowed the TIPGA therapeutic nanoplatform with photodynamic therapy (PDT) performance. Furthermore, a polydopamine (PDA) membrane was coated on the therapeutic nanoplatform to improve stability and gambogic acid (GA) as an antitumor drug and heat shock protein (HSP) inhibitor was loaded onto the nanoplatform. A transmembrane glycoprotein mucin (MUC1) aptamer (Apt-M) was covalently bound to the therapeutic nanoplatform, endowing this therapeutic nanoplatform with an excellent active tumor targeting ability. The TIPGA nanoplatform exhibited efficient cellular uptake mediated by Apt-M and the intracellular release of GA triggered by glutathione (GSH). GA downregulated HSP90 expression, reducing the tumor cell resistance to thermal stresses. Encouragingly, experiments demonstrated that the TIPGA therapeutic nanoplatform could sharply accumulate in MCF-7 tumors due to its potent active targeting capability and displayed superior tumor suppressive ability through targeted PTT/PDT/CHT at low temperatures. Our findings reveal a novel approach of the Ti3C2-based therapeutic nanoplatform for targeted PTT/PDT/CHT at low temperatures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Shanxi Provincial Key Laboratory of Chemical Biosensing, Shanxi Datong University, Datong 037009, P. R. China.
- School of Agriculture and Life Sciences, Shanxi Datong University, Datong 037009, P. R. China.
- School of Chemistry and Material Science, Shanxi Normal University, Taiyuan 030002, P. R. China.
ORCID-Profile: Yunfeng Bai, Feng Feng
Förderung
- National Natural Science Foundation of China
- Fundamental Research Program of Shanxi Datong University
- Key Scientific and Technological Projects of Datong City
- Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province
- Postgraduate science and technology innovation project of Shanxi Normal University
- Scientific and Technological Innovation Programs of Higher Education Institutions in Shanxi
- Fundamental Research Program of Datong City
- Fundamental Research Program of Shanxi Province
Zitieren
APA
Bai, Z., Zhao, L., Xin, Z., Li, J., Bai, Y., & Feng, F. (2025). Smart Therapeutic Nanoplatform Based on Ti 3 C 2 MXenes for Tumor-Targeted PTT/PDT/CHT at Low Temperatures. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00659
Vancouver
Bai Z, Zhao L, Xin Z, Li J, Bai Y, Feng F. Smart Therapeutic Nanoplatform Based on Ti 3 C 2 MXenes for Tumor-Targeted PTT/PDT/CHT at Low Temperatures. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.5c00659
BibTeX
@article{Bai2025,
author = {Bai, Zhiqiang and Zhao, Lu and Xin, Zhihui and Li, Jiang and Bai, Yunfeng and Feng, Feng},
title = {Smart Therapeutic Nanoplatform Based on Ti 3 C 2 MXenes for Tumor-Targeted PTT/PDT/CHT at Low Temperatures},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.5c00659}
}
EUVIMED